Fractyl Health GUTS Income Statement (2023-2026)

NASDAQ GUTS
$0.69 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 2.06M2.09M2.10M2.11M29.74M47.91M48.09M48.76M48.92M49.92M64.65M75.82M158.65M159.18M
Revenue & cost
Revenue (Quarter) 0.01M0.07M0.04M0.01M0.03M0.04M0.01M0.00M
Gross Profit (Quarter) 0.00M0.03M0.01M0.01M0.01M0.02M0.01M0.00M
Operating items
Research & Development (Quarter) 9.35M9.14M9.38M10.17M14.42M16.76M19.00M20.28M19.43M21.15M17.46M16.49M15.60M13.81M
Selling, General & Administrative (Quarter) 2.76M2.76M4.50M2.82M7.13M6.24M4.80M4.93M5.32M4.93M5.24M6.79M5.22M5.28M
Operating Expenses (Quarter) 12.11M11.90M13.88M12.99M21.56M23.00M23.80M25.21M24.76M26.08M22.69M23.28M20.82M19.10M
Operating Income (Quarter) -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M-24.76M-26.08M-22.69M-23.28M-20.82M-19.10M
EBIT (Quarter) -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M-24.76M-26.08M-22.69M-23.28M-20.82M-19.10M
Non-operating items
Interest & Investment Income (Quarter) 0.42M0.15M0.23M0.46M1.10M1.38M0.95M0.73M0.50M0.23M0.17M0.65M0.59M0.43M
Other Non Operating Income (Quarter) 0.01M-0.02M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M
Non Operating Income (Quarter) 0.17M-18.36M-1.87M-6.20M18.22M5.76M0.62M0.24M1.02M-1.81M-22.91M-20.44M30.04M-6.44M
Net income details
EBT (Quarter) -11.69M-11.72M-13.65M-13.13M-26.08M-82.53M-82.40M-25.62M-80.93M-81.08M-76.30M-23.72M-26.13M-67.99M
Profit After Tax (Quarter) -11.93M-30.23M-15.75M-19.18M-3.32M-17.23M-23.17M-24.97M-23.73M-27.89M-45.60M-43.73M9.22M-25.54M
Income from Continuing Operations (Quarter) -11.69M-11.72M-13.65M-13.13M-26.08M-82.53M-82.40M-25.62M-80.93M-81.08M-76.30M-23.72M-26.13M-67.99M
Consolidated Net Income (Quarter) -11.69M-11.72M-13.65M-13.13M-26.08M-82.53M-82.40M-25.62M-80.93M-81.08M-76.30M-23.72M-26.13M-67.99M
Income towards Parent Company (Quarter) -11.69M-11.72M-13.65M-13.13M-26.08M-82.53M-82.40M-25.62M-80.93M-81.08M-76.30M-23.72M-26.13M-67.99M
Preferred Dividend Payments (Quarter) 4.24M4.28M4.33M4.33M1.74M
Net Income towards Common Stockholders (Quarter) -16.17M-34.52M-20.08M-23.51M-5.06M-17.23M-23.17M-24.97M-23.73M-27.89M-45.60M-43.73M-26.13M-67.99M
Additional items
EPS (Basic) (Quarter) -7.87-16.62-9.61-11.30-0.17-0.36-0.48-0.57-0.49-0.57-0.71-0.58-0.16-0.43
EPS (Diluted) (Quarter) -7.87-16.62-9.61-11.30-0.17-0.36-0.48-0.57-0.49-0.57-0.71-0.58-0.16-0.43
Shares Outstanding (Quarter) 2.06M2.08M2.09M2.08M29.74M47.90M47.97M43.54M48.87M49.04M64.65M75.82M158.49M158.65M
Shares Outstanding (Diluted) (Quarter) 2.06M2.08M2.09M2.08M29.74M47.90M47.97M43.54M48.87M49.04M64.65M75.82M158.49M158.65M
EBITDA (Quarter) -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M-24.76M-26.08M-22.69M-23.28M-20.82M-19.10M
Interest Expenses (Quarter) 0.61M5.64M60.92M59.56M1.14M56.67M55.22M53.77M1.08M5.91M49.32M